Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 24, 2026
Why Is Bloom Energy (BE) Stock Down -5.91% Today?

Why Is Bloom Energy (BE) Stock Down -5.91% Today?

Key Takeaways

  • BE fell roughly 5.91% to $258.94, down from a prior close of $275.19.
  • The primary catalyst was an Oracle force majeure notice tied to its New Mexico data center, Project Jupiter, which relies on Bloom Energy fuel cells.
  • A broader pullback in AI and semiconductor names, alongside higher Treasury yields and oil prices, added pressure on high-growth stocks.
  • The decline partly offset a powerful 2026 rally — the stock is still up more than 200% year-to-date on data-center power demand.
  • Mizuho raised its price target to $351 while reiterating an Outperform rating, a counterweight that did not stem the session's selling.
  • Traders are watching for updates on the Project Jupiter timeline, sector sentiment, and Bloom's next earnings report.

Opening Summary

Bloom Energy Corporation (BE) designs, manufactures, and installs solid oxide fuel cell "Energy Server" systems that generate on-site power without a grid connection — a solution that has made the company a central player in powering AI data centers. In today's session, shares dropped 5.91% to $258.94, down from the prior close of $275.19. Markets attributed the decline primarily to an Oracle force majeure notice concerning its New Mexico data center campus, Project Jupiter, which is designed to run on Bloom fuel cells.

Oracle Force Majeure Notice Rattles Project Jupiter

The sharpest driver of the move was news that ORCL issued a force majeure notice related to its New Mexico data center project. Project Jupiter has been a flagship validation of Bloom's technology, with Oracle's campus expected to rely heavily on Bloom Energy fuel cells rather than traditional gas turbines or diesel backup. A force majeure notice signals potential delays or disruptions to the project's timeline, raising immediate questions about the pace of Bloom's deliveries and revenue recognition tied to one of its most prominent customers.

The market reaction was swift and concentrated. Bloom Energy shares fell sharply in pre-market trading, briefly down nearly 7%, before settling lower in regular trading. The same catalyst also weighed on OWL (Blue Owl Capital), a data-center investor exposed to the New Mexico campus, underscoring that investors viewed the news as a potential setback for the broader project rather than a company-specific operational failure.

Broader AI and Growth-Stock Pressure

The Oracle development landed during a session in which AI and semiconductor equities were already under pressure, as investors reassessed the pace of AI infrastructure spending. Higher Treasury yields and elevated oil prices further weighed on richly valued growth stocks, a category where Bloom Energy sits comfortably after its outsized run. Because Bloom's valuation reflects aggressive expectations for data-center power demand, any signal — real or perceived — that a marquee project could slow tends to amplify downside volatility.

Analyst Support Offsets, But Does Not Reverse, the Decline

Even as the stock fell, some Wall Street analysts reiterated constructive views. Mizuho raised its price target on BE to $351 from $242 while maintaining an Outperform rating, citing stronger pricing power, improving delivery visibility into the second half of 2026 and 2027, and confidence that permitting delays are more likely to affect timing than underlying demand. The upgrade, however, was not enough to offset the negative sentiment surrounding the Oracle news in the near term.

Market Context and Trading Activity

The move reflected event-driven selling rather than a broad market collapse, with the stock diverging from the pattern of recent weeks. Bloom Energy has been one of the market's standout AI-infrastructure stories, boosted by its recent addition to the S&P 500, a $25 billion financing framework with Brookfield Asset Management, and a rapidly expanding backlog of data-center customers. Against that backdrop, today's pullback looked like a sharp reassessment of a single high-profile project's near-term trajectory within an otherwise strong secular growth narrative.

Trading was active throughout the morning as investors digested the force majeure headline, with the stock breaking below several recent short-term support levels as sellers dominated early price action. The move was idiosyncratic — concentrated in Bloom and its project partners — rather than a synchronized sell-off across the fuel-cell or clean-energy complex.

What Comes Next for BE

Investors will be closely watching for clarification from Oracle and Bloom Energy on the scope and duration of the force majeure notice, as well as any revised timelines for Project Jupiter deliveries. The company's next earnings report and any updated guidance will be critical in signaling whether the disruption is temporary or more structural. Beyond the immediate catalyst, sentiment remains tied to the broader AI data-center buildout, financing partnerships, and the company's ability to convert its growing backlog into delivered revenue. Risks include project timing, elevated valuation, supply-chain considerations, and the potential for further volatility given the stock's rapid appreciation this year.

Trending AI Robots

For traders seeking a systematic approach to fast-moving names like BE, Tickeron's Trending AI Robots page offers a curated view of its top-performing AI trading bots. Tickeron provides hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore diverse automated approaches. Consider reviewing the page to see which AI-driven strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


BE in upward trend: 10-day moving average crossed above 50-day moving average on September 09, 2026

The 10-day moving average for BE crossed bullishly above the 50-day moving average on September 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 23, 2026. You may want to consider a long position or call options on BE as a result. In 61 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for BE just turned positive on August 25, 2026. Looking at past instances where BE's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.

BE moved above its 50-day moving average on September 03, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where BE advanced for three days, in 264 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 248 of 270 cases where BE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for BE moved out of overbought territory on September 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 33 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 60 cases where BE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

BE broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. BE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BE's P/B Ratio (50.505) is very high in comparison to the industry average of (7.880). BE's P/E Ratio (359.130) is considerably higher than the industry average of (58.103). Projected Growth (PEG Ratio) (0.625) is also within normal values, averaging (2.905). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (24.876) is also within normal values, averaging (8.080).

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.65B. The market cap for tickers in the group ranges from 750 to 209.6B. CYATY holds the highest valuation in this group at 209.6B. The lowest valued company is EDYYF at 750.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was -1%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -1%. CBAT experienced the highest price growth at 43%, while SDST experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -20%. For the same stocks of the Industry, the average monthly volume growth was -36% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 75
Price Growth Rating: 63
SMR Rating: 83
Profit Risk Rating: 84
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
BE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of on-site electric power solutions

Industry ElectricalProducts

Industry
Electrical Products
Address
4353 North First Street
Phone
+1 408 543-1500
Employees
2214
Web
https://www.bloomenergy.com
Interact to see
Advertisement
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.